Download PDF
Thromb Haemost 2000; 84(06): 1127-1128
DOI: 10.1055/s-0037-1614188
Letters to the Editor
Schattauer GmbH

Ristocetin Cofactor and Collagen Binding Activities Normalized to Antigen Levels for a Rapid Diagnosis of Type 2 von Willebrand Disease

Single Center Comparison of Four Different Assays
Augusto B. Federici
1   From Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Maggiore Hospital, University of Milan, Milano, Italy
,
Maria Teresa Canciani
1   From Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Maggiore Hospital, University of Milan, Milano, Italy
,
Ileana Forza
1   From Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Maggiore Hospital, University of Milan, Milano, Italy
,
Giovanna Cozzi
1   From Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Maggiore Hospital, University of Milan, Milano, Italy
› Author Affiliations
Further Information

Publication History

Received 13 June 2000

Accepted after revision 23 August 2000

Publication Date:
13 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Federici AB. Diagnosis of von Willebrand disease. Haemophilia 1998; 04: 654-60.
    CrossrefPubMedGoogle Scholar
  • 2 Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 MacFarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
    PubMedGoogle Scholar
  • 4 Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J. Laboratory testing for von Willebrand’s disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thromb Haemost 1999; 82: 1276-82.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997; 78: 1272-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Preston FE. Assays for von Willebrand factor functional activity: a UK NEQAS survey. Thromb Haemost 1998; 80: 863.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H. A reliable and reproducible ELIS A method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2000; 83: 107-13.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Brown IE, Bosak JO. An ELIS A test for the binding of von Willebrand antigen to collagen. Thromb Res 1986; 43: 303-11.
    CrossrefPubMedGoogle Scholar
  • 9 Favaloro EJ. Collagen binding assay for von Willebrand Factor (v WF :CB A): detection of von Willebrand’s disease, and discrimination of vWD subtypes, depends on collagen source. Thromb Haemost 2000; 83: 127-35.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 iekmann I, Turecek PL, Schwarz HP. The determination of von Willebrand factor activity by collagen binding assay. Haemophilia 1998; 04 (Suppl. 03) 15-24.
    CrossrefPubMedGoogle Scholar
  • 11 Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G. Heterogeneity of Type I von Willebrand Disease: Evidence for a Subgroup with an Abnormal von Willebrand Factor. Blood 1985; 66 (04) 796-802.
    PubMedGoogle Scholar